Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

Clinical trial NCT01251978 · COMPLETED

Trial details

NCT number: NCT01251978
Sponsor: New England Retina Associates
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Choroidal Melanoma

Start date: 2010-07-01
Primary completion: 2012-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.